Wikiwand AI

ALK+ large B-cell lymphoma

From Wikipedia, the free encyclopedia

ALK+ large B-cell lymphoma is a type of lymphoma.[1][2]: 378  It was first reported in 1997.[2]: 378 [3][4] It is a rare, aggressive large B-cell process that shows ALK expression.[2]: 378 [3][5] It is distinct from anaplastic large cell lymphoma, a T-cell lymphoma.[2]: 564 [3][6]

Pathophysiology

Upregulation of ALK is mainly due to chromosomal translocation t(2;17), resulting in a fusion gene of CLTC with ALK,[4][7] but can rarely be due to t(2;5), fusing NPM1 with ALK;[2]: 378  the later is the usual finding in anaplastic large cell lymphoma (ALCL).[4][7] The t(2;17) translocation occurs in less than 1% of cases of ALK+ ALCL, but has been identified in inflammatory myofibroblastic tumors.[3]

There is no association with Epstein–Barr virus[2]: 378 [6] or HHV8,[6] or immunosuppression.[2]: 378  The cells are CD20 and CD30 negative,[8]: 306  showing weak focal expression in 3% and 6% respectively.[2]: 378  They are EMA and CD138 positive,[8]: 306  showing 100% expression respectively.[2]: 378 

Diagnosis

The median age of diagnosis is approximately late thirties to early forties.[2]: 378 [3][5] The estimates of childhood disease vary (8%,[9] 15%,[3] 30%[2]: 378 ) but it can be seen at any age.[5][8]: 306 

The disease usually arises in lymph nodes, particularly the neck, but extranodal involvement, including in the gastrointestinal tract, nasal cavity, ovary and brain, has been described.[3][5] Morphologically, there are large immunoblast-like cells with large central nucleoli, often cellular clusters, with a predilection for the lymph node sinuses[2]: 378 [4][8]: 306  in a cohesive pattern that can suggest carcinoma cells.[2]: 378 [8]: 306 

Treatment

See also

References

Related Articles

Timelines

Top Qs

Fact Checks